277
Participants
Start Date
June 30, 2012
Primary Completion Date
October 31, 2017
Study Completion Date
October 31, 2017
MAL-PDT re-treatment
a schedule of 1 single treatment of Metvix(R)-Photodynamic therapy with re-treatment of non-complete responders by 3 months
usual MAL-PDT
schedule of 2 standard Metvix(R)- Photodynamic therapy treatment sessions 1 week apart.
Dept Dermatology, Haukeland University Hospital, Bergen
Central Hospital Førde, Førde
Hudlegekontoret Lillehammer AS, Lillehammer
Akerskus Dermatological Centre, Lørenskog
Dept Dermatology, Oslo University Hospital, Oslo
Dept Surgery, Oslo University Hospital, Oslo
Hudlegen på Holtet, Oslo
Dept Dermato-Venereology, Stavanger University Hospital, Stavanger
Department of Cancer Research and Molecular Medicine, NTNU, Trondheim
Akershus Dermatological Centre
UNKNOWN
Helse Stavanger HF
OTHER_GOV
Oslo University Hospital
OTHER
Førde Central Hospital
OTHER
Haukeland University Hospital
OTHER
Hudlegekontoret Lillehammer
UNKNOWN
Hudlegene på Holtet DA
UNKNOWN
Norwegian University of Science and Technology
OTHER